Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of Non-Viral, Trophoblast-Specific Gene Delivery for Placental Therapy

16 Oct 2015

Abstract excerpt

Low birth weight is associated with both short term problems and the fetal programming of adult onset diseases, including an increased risk of obesity, diabetes and cardiovascular disease. Placental insufficiency leading to intrauterine growth restriction (IUGR) contributes to the prevalence of diseases with developmental origins. Currently there are no therapies for IUGR or placental insufficiency. To address...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26473479
DOI: 10.1371/journal.pone.0140879

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of Non-Viral, Trophoblast-Specific Gene Delivery for Placental TherapyPMID 26473479Read ↗

Maternal, placental and fetal response to a non-viral, polymeric nanoparticle gene therapy in nonhuman primatesSemantic proximity Read ↗

Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical ApplicationSemantic proximity Read ↗

Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy interventionSemantic proximity Read ↗

Nanoparticle-mediated delivery of placental gene therapy via uterine artery catheterization in a pregnant rhesus macaqueSemantic proximity Read ↗

Nanoparticle‐mediated transgene expression of insulin‐like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrationsSemantic proximity Read ↗

Placental Nanoparticle-mediated IGF1 Gene Therapy Corrects Fetal Growth Restriction in a Guinea Pig ModelSemantic proximity Read ↗

Placental <i>hIGF1</i> nanoparticle gene therapy in guinea pigs ameliorates fetal growth restriction-associated changes in hepatic lipid and glucose metabolism-related signaling pathways in a fetal sex-specific mannerSemantic proximity Read ↗

Nanoparticle-mediated transgene expression of <i>insulin-like growth factor 1</i> in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrationsSemantic proximity Read ↗

Placental treatment with <i>insulin-like growth factor 1</i> via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/deciduaSemantic proximity Read ↗

Mid-pregnancy placental transcriptome in a model of placental insufficiency with and without novel interventionSemantic proximity Read ↗

Placenta <i>hIGF1</i> nanoparticle treatment in guinea pigs mitigates fetal sex dependent FGR-associated effects on kidney structure and blood pressure-related signaling pathwaysSemantic proximity Read ↗

Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.